QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
NASDAQ:STAA

STAAR Surgical - STAA Stock Forecast, Price & News

$102.03
-2.88 (-2.75%)
(As of 08/16/2022 12:00 AM ET)
Add
Compare
Today's Range
$100.93
$105.76
50-Day Range
$62.10
$111.58
52-Week Range
$49.03
$163.08
Volume
538,541 shs
Average Volume
485,678 shs
Market Capitalization
$4.90 billion
P/E Ratio
152.28
Dividend Yield
N/A
Price Target
$106.83

STAAR Surgical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
4.7% Upside
$106.83 Price Target
Short Interest
Bearish
6.12% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.73
Upright™ Environmental Score
News Sentiment
0.50mentions of STAAR Surgical in the last 14 days
Based on 24 Articles This Week
Insider Trading
Selling Shares
$2.01 M Sold Last Quarter
Proj. Earnings Growth
72.31%
From $0.65 to $1.12 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.94 out of 5 stars

Medical Sector

849th out of 1,124 stocks

Ophthalmic Goods Industry

7th out of 7 stocks

STAA stock logo

About STAAR Surgical (NASDAQ:STAA) Stock

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical Price Performance

Shares of NASDAQ:STAA opened at $104.91 on Tuesday. STAAR Surgical has a 1 year low of $49.03 and a 1 year high of $163.08. The business has a 50 day simple moving average of $76.46 and a two-hundred day simple moving average of $71.02. The firm has a market capitalization of $5.02 billion, a PE ratio of 156.58 and a beta of 1.09.

STAAR Surgical (NASDAQ:STAA - Get Rating) last announced its earnings results on Wednesday, August 10th. The medical instruments supplier reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.02. STAAR Surgical had a return on equity of 13.99% and a net margin of 12.84%. The business had revenue of $81.10 million during the quarter, compared to analyst estimates of $80.12 million. During the same quarter in the previous year, the business earned $0.19 earnings per share. The company's revenue for the quarter was up 30.0% compared to the same quarter last year. Equities research analysts expect that STAAR Surgical will post 0.65 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

STAA has been the topic of several research reports. Canaccord Genuity Group lifted their target price on STAAR Surgical from $81.00 to $89.00 and gave the stock a "buy" rating in a report on Tuesday, April 26th. BTIG Research lifted their price target on STAAR Surgical from $98.00 to $103.00 in a research report on Thursday, August 11th. Canaccord Genuity Group lifted their price target on STAAR Surgical from $89.00 to $97.00 in a research report on Thursday, August 11th. Jefferies Financial Group dropped their price target on STAAR Surgical from $165.00 to $125.00 in a research report on Thursday, August 11th. Finally, Needham & Company LLC lifted their price target on STAAR Surgical from $87.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, August 11th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, STAAR Surgical presently has an average rating of "Moderate Buy" and a consensus target price of $106.83.

Insider Buying and Selling at STAAR Surgical

In related news, CEO Caren L. Mason sold 35,000 shares of the business's stock in a transaction that occurred on Thursday, May 19th. The stock was sold at an average price of $57.49, for a total value of $2,012,150.00. Following the completion of the sale, the chief executive officer now owns 83,645 shares in the company, valued at $4,808,751.05. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 2.60% of the company's stock.

Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Stock News Headlines

STAAR Surgical (NASDAQ:STAA) Price Target Cut to $125.00
Disney To $154? Here Are 5 Other Price Target Changes For Thursday
STAAR Surgical Company News
Should You Buy Stocks When the Market Crashes?
See More Headlines
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Company Calendar

Last Earnings
8/10/2022
Today
8/16/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:STAA
CUSIP
85231230
Employees
692
Year Founded
1982

Price Target and Rating

Average Stock Price Forecast
$106.83
High Stock Price Forecast
$125.00
Low Stock Price Forecast
$89.00
Forecasted Upside/Downside
+4.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$24.50 million
Pretax Margin
15.80%

Debt

Sales & Book Value

Annual Sales
$230.47 million
Cash Flow
$0.61 per share
Book Value
$5.43 per share

Miscellaneous

Free Float
46,789,000
Market Cap
$4.90 billion
Optionable
Optionable
Beta
1.09

Social Links















STAA Stock - Frequently Asked Questions

Should I buy or sell STAAR Surgical stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" STAA shares.
View STAA analyst ratings
or view top-rated stocks.

What is STAAR Surgical's stock price forecast for 2022?

5 brokerages have issued twelve-month target prices for STAAR Surgical's stock. Their STAA share price forecasts range from $89.00 to $125.00. On average, they expect the company's share price to reach $106.83 in the next year. This suggests a possible upside of 4.7% from the stock's current price.
View analysts price targets for STAA
or view top-rated stocks among Wall Street analysts.

How have STAA shares performed in 2022?

STAAR Surgical's stock was trading at $91.30 at the beginning of 2022. Since then, STAA shares have increased by 11.8% and is now trading at $102.03.
View the best growth stocks for 2022 here
.

When is STAAR Surgical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our STAA earnings forecast
.

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) posted its earnings results on Wednesday, August, 10th. The medical instruments supplier reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.24 by $0.02. The medical instruments supplier had revenue of $81.10 million for the quarter, compared to the consensus estimate of $80.12 million. STAAR Surgical had a trailing twelve-month return on equity of 13.99% and a net margin of 12.84%. STAAR Surgical's quarterly revenue was up 30.0% on a year-over-year basis. During the same period last year, the company earned $0.19 EPS.

What guidance has STAAR Surgical issued on next quarter's earnings?

STAAR Surgical issued an update on its FY 2022 earnings guidance on Friday, August, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $295.00 million-$295.00 million, compared to the consensus revenue estimate of $295.67 million.

What is Caren Mason's approval rating as STAAR Surgical's CEO?

6 employees have rated STAAR Surgical Chief Executive Officer Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among the company's employees.

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Baillie Gifford & Co. (11.05%), State Street Corp (3.26%), Palo Alto Investors LP (2.31%), Geneva Capital Management LLC (1.90%), Ensign Peak Advisors Inc (1.37%) and Northern Trust Corp (1.28%). Insiders that own company stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams, Samuel J Gesten and Scott D Barnes.
View institutional ownership trends
.

How do I buy shares of STAAR Surgical?

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $102.03.

How much money does STAAR Surgical make?

STAAR Surgical (NASDAQ:STAA) has a market capitalization of $4.90 billion and generates $230.47 million in revenue each year. The medical instruments supplier earns $24.50 million in net income (profit) each year or $0.67 on an earnings per share basis.

How many employees does STAAR Surgical have?

The company employs 692 workers across the globe.

Does STAAR Surgical have any subsidiaries?
The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.
Read More
When was STAAR Surgical founded?

STAAR Surgical was founded in 1982.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The official website for the company is www.staar.com. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at bmoore@staar.com, or via fax at 626-303-2962.

This page (NASDAQ:STAA) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.